136 related articles for article (PubMed ID: 1933810)
41. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
42. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma.
Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
Gynecol Oncol; 1996 Aug; 62(2):254-9. PubMed ID: 8751558
[TBL] [Abstract][Full Text] [Related]
43. Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer.
Gasparini G; Meli S; Panizzoni GA; Visonà A; Boracchi P; Bevilacqua P; Marubini E; Pozza F
Breast Cancer Res Treat; 1992 Mar; 20(3):195-204. PubMed ID: 1571572
[TBL] [Abstract][Full Text] [Related]
44. DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer.
Witzig TE; Ingle JN; Cha SS; Schaid DJ; Tabery RL; Wold LE; Grant C; Gonchoroff NJ; Katzmann JA
Cancer; 1994 Sep; 74(6):1752-61. PubMed ID: 8082078
[TBL] [Abstract][Full Text] [Related]
45. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.
Uyterlinde AM; Baak JP; Schipper NW; Peterse HJ; Meijer JW; Vooys PG; Matze E
Int J Cancer; 1991 May; 48(2):173-81. PubMed ID: 2019464
[TBL] [Abstract][Full Text] [Related]
47. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
48. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
[TBL] [Abstract][Full Text] [Related]
49. Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.
Scheistrøen M; Tropé C; Koern J; Pettersen EO; Abeler VM; Kristensen GB
Cancer; 1995 Jan; 75(1):72-80. PubMed ID: 7804980
[TBL] [Abstract][Full Text] [Related]
50. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
51. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768
[TBL] [Abstract][Full Text] [Related]
52. Prognostic markers in node-negative breast cancer: a prospective study.
Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
[TBL] [Abstract][Full Text] [Related]
53. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
[TBL] [Abstract][Full Text] [Related]
54. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
Hara S; Tomita M
Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
[TBL] [Abstract][Full Text] [Related]
55. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
[TBL] [Abstract][Full Text] [Related]
56. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
57. The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients.
Kute TE; Muss HB; Cooper MR; Case LD; Buss D; Stanley V; Gregory B; Galleshaw J; Booher K
Cancer; 1990 Oct; 66(8):1810-6. PubMed ID: 2208036
[TBL] [Abstract][Full Text] [Related]
58. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
59. Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content.
Jakobsen A; Poulsen HS; Madsen EL; Petersen SE; Hansen HS
Acta Radiol Oncol; 1984; 23(2-3):103-7. PubMed ID: 6331077
[TBL] [Abstract][Full Text] [Related]
60. Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry.
O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Rubens RD; Richards MA
J Clin Oncol; 1990 Dec; 8(12):2040-6. PubMed ID: 2230896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
